Health News-RSS Feeds

Subscribe to Health News-RSS Feeds feed Health News-RSS Feeds
Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.
Updated: 18 min 55 sec ago

Malawi can eradicate HIV infections says U.S. doctor who discovered AIDS virus

April 18, 2018 - 10:03pm
BLANTYRE (Reuters) - Malawi, which has one of the highest rates of the deadly HIV/AIDS infections, is on course to eradicate the virus, Jay Levy who co-discovered the AIDS virus 35 years ago said.

Raising retirement age may hit least-educated workers hardest

April 18, 2018 - 9:49pm
Reuters Health - People with little education and low socioeconomic status are more likely to leave the workforce in midlife for health reasons than better educated and higher-status workers, suggests a review of research across four developed countries.

Abbott sticks to earlier forecasts, disappoints investors

April 18, 2018 - 9:41pm
(Reuters) - Abbott Laboratories' just beat expectations for first quarter profits and revenue on Wednesday but stuck to a full-year profit forecast some investors had expected would be raised, sending the healthcare company's shares lower.

Miami among cities at risk from yellow fever spread : study

April 18, 2018 - 9:17pm
GENEVA (Reuters) - Miami is at risk of a deadly yellow fever outbreak because the disease could thrive there but the city has no checks on travelers arriving from endemic zones, a study to be published by the World Health Organization showed.

Kentucky accuses J&J of contributing to opioid epidemic

April 18, 2018 - 8:26pm
(Reuters) - Kentucky's attorney general on Wednesday sued Johnson & Johnson, accusing the pharmaceutical manufacturer of devising a deceptive marketing scheme that mischaracterized the risk of opioid abuse and addiction.

GSK flags pharma M&A ambitions by poaching Roche deal-maker

April 18, 2018 - 8:08pm
LONDON (Reuters) - GlaxoSmithKline signaled its intention to boost its drug pipeline through deals on Wednesday by hiring Kevin Sin from Roche's Genentech unit to lead a worldwide search for promising experimental products.

Industry fears disruption as EU excludes UK from drug approvals

April 18, 2018 - 7:23pm
LONDON (Reuters) - A European decision to exclude Britain from the EU's drug approval system from March 30 2019 - the day after Brexit - has raised alarm among drugmakers, who fear the abrupt change could disrupt medicine supplies to patients.

GSK grabs Roche cancer expert to lead pharma pipeline deals

April 18, 2018 - 7:07pm
LONDON (Reuters) - GlaxoSmithKline said on Wednesday it had hired Kevin Sin from Roche's Genentech unit to head worldwide business development for pharmaceuticals research and development.

Abbott's quarterly profit, sales beat Street estimates

April 18, 2018 - 5:51pm
(Reuters) - Abbott Laboratories reported better-than-expected quarterly profit and sales, helped by growth across its businesses and device launches.

How healthy is too healthy? EU warns about green tea supplements

April 18, 2018 - 5:45pm
BRUSSELS (Reuters) - Taking high doses of supplements containing green tea extracts may be associated with liver damage, according to new research from the European Food Safety Authority (EFSA).

Novo Nordisk, Red Cross team up to tackle chronic diseases in conflict zones

April 18, 2018 - 1:20pm
COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk and aid agency Red Cross have teamed up to try to improve the treatment of chronic diseases among the millions affected by conflicts and humanitarian crises in countries such as Syria and Yemen.

Canada seeks U.S. help to solve EpiPen shortage

April 18, 2018 - 4:44am
TORONTO (Reuters) - Canada said on Tuesday it is working with the U.S. Food and Drug Administration to access supplies of Mylan N.V.'s EpiPen emergency allergy antidote amid a global shortage that has spared the United States.

Global leaders seek to reignite fight against deadly malaria

April 18, 2018 - 4:36am
LONDON, April 18 (Reuters) - Renewed action and boosted funding to fight malaria could prevent 350 million cases of the disease in the next five years and save 650,000 lives across commonwealth countries, health experts said on Wednesday.

Marijuana-related ER visits by Colorado teens on the rise

April 18, 2018 - 2:28am
(Reuters Health) - More visits to the emergency room by teens in Colorado are related to marijuana use than in the past, suggesting an impact of the drug's legalization that needs closer attention, researchers say.

Amgen's Aimovig halved migraine days in 30 percent of trial patients

April 18, 2018 - 1:40am
LOS ANGELES (Reuters) - A late-stage trial of Amgen Inc's experimental drug Aimovig found that it reduced episodic migraines by at least half in 30 percent of patients who had failed up to four previous treatments, while 14 percent of placebo patients achieved that goal, the company said on Tuesday.

Canada says working with FDA to address EpiPen shortage

April 18, 2018 - 1:21am
TORONTO (Reuters) - Canada's government health agency said on Tuesday it is working with the U.S. Food and Drug Administration to address a shortage of Mylan N.V.'s EpiPen emergency allergy antidote that has hit several countries outside of the United States, where it is manufactured.

More activity, healthier diet tied to extended survival after colon cancer

April 18, 2018 - 1:12am
(Reuters Health) - Colon cancer survivors with healthier lifestyles may live longer, a recent U.S. study suggests.

Older adults may not need vitamin D to prevent falls and fractures

April 18, 2018 - 12:54am
(Reuters Health) - Many older adults should avoid taking vitamin D and calcium supplements to prevent falls and fractures, and focus instead on exercises to improve balance and coordination, U.S. doctors recommend.

U.S. drug agency proposes rules to rein in opioid manufacturing

April 18, 2018 - 12:13am
WASHINGTON (Reuters) - The U.S. Drug Enforcement Administration on Tuesday unveiled plans to rein in the amount of opioids that can be manufactured by drugmakers in a given year in an effort to combat the deadly opioid epidemic in the United States.

U.S. drug agency to propose rules to rein in opioid manufacturing

April 17, 2018 - 11:40pm
WASHINGTON (Reuters) - The U.S. Drug Enforcement Administration on Tuesday unveiled plans to rein in the amount of opioids that can be manufactured by drugmakers in a given year, in an effort to combat the deadly opioid epidemic that has plagued the United States.